164 related articles for article (PubMed ID: 30290291)
1. Opioid and cocaine use among primary care patients on buprenorphine-Self-report and urine drug tests.
Bagley SM; Cheng DM; Winter M; Alford DP; LaBelle C; Walley AY; Samet JH
Drug Alcohol Depend; 2018 Nov; 192():245-249. PubMed ID: 30290291
[TBL] [Abstract][Full Text] [Related]
2. Urine Drug Test Results Among Adolescents and Young Adults in an Outpatient Office-Based Opioid Treatment Program.
Ramey OL; Bonny AE; Silva Almodóvar A; Nahata MC
J Adolesc Health; 2023 Jul; 73(1):141-147. PubMed ID: 37031090
[TBL] [Abstract][Full Text] [Related]
3. Treatment changes following aberrant urine drug test results for patients prescribed chronic opioid therapy.
Morasco BJ; Krebs EE; Cavanagh R; Hyde S; Crain A; Dobscha SK
J Opioid Manag; 2015; 11(1):45-51. PubMed ID: 25750164
[TBL] [Abstract][Full Text] [Related]
4. Psychiatric Comorbidity and Substance Use Outcomes in an Office-Based Buprenorphine Program Six Months Following Hurricane Sandy.
Tofighi B; Grossman E; Goldfeld KS; Williams AR; Rotrosen J; Lee JD
Subst Use Misuse; 2015; 50(12):1571-8. PubMed ID: 26623697
[TBL] [Abstract][Full Text] [Related]
5. Prediction of treatment outcome by baseline urine cocaine results and self-reported cocaine use for cocaine and opioid dependence.
Sofuoglu M; Gonzalez G; Poling J; Kosten TR
Am J Drug Alcohol Abuse; 2003; 29(4):713-27. PubMed ID: 14713135
[TBL] [Abstract][Full Text] [Related]
6. Emergency Department-Initiated Buprenorphine for Opioid Dependence with Continuation in Primary Care: Outcomes During and After Intervention.
D'Onofrio G; Chawarski MC; O'Connor PG; Pantalon MV; Busch SH; Owens PH; Hawk K; Bernstein SL; Fiellin DA
J Gen Intern Med; 2017 Jun; 32(6):660-666. PubMed ID: 28194688
[TBL] [Abstract][Full Text] [Related]
7. Methamphetamine use and illicit opioid use during buprenorphine treatment.
Kratina-Hathaway Z; Radick AC; Leroux BG; Blalock K; Kim TW; Darnton J; Saxon AJ; Samet JH; Tsui JI
J Subst Use Addict Treat; 2023 Aug; 151():. PubMed ID: 37811395
[TBL] [Abstract][Full Text] [Related]
8. Chronic opioid therapy urine drug testing in primary care: prevalence and predictors of aberrant results.
Turner JA; Saunders K; Shortreed SM; LeResche L; Riddell K; Rapp SE; Von Korff M
J Gen Intern Med; 2014 Dec; 29(12):1663-71. PubMed ID: 25217208
[TBL] [Abstract][Full Text] [Related]
9. Addressing discordant quantitative urine buprenorphine and norbuprenorphine levels: Case examples in opioid use disorder.
Holt SR; Donroe JH; Cavallo DA; Tetrault JM
Drug Alcohol Depend; 2018 May; 186():171-174. PubMed ID: 29579725
[TBL] [Abstract][Full Text] [Related]
10. Prescription opioid abuse and misuse: gap between primary-care investigator assessment and actual extent of these behaviors among patients with chronic pain.
Setnik B; Roland CL; Pixton GC; Sommerville KW
Postgrad Med; 2017 Jan; 129(1):5-11. PubMed ID: 27782769
[TBL] [Abstract][Full Text] [Related]
11. Rate of Fentanyl Positivity Among Urine Drug Test Results Positive for Cocaine or Methamphetamine.
LaRue L; Twillman RK; Dawson E; Whitley P; Frasco MA; Huskey A; Guevara MG
JAMA Netw Open; 2019 Apr; 2(4):e192851. PubMed ID: 31026029
[TBL] [Abstract][Full Text] [Related]
12. Chronic opioid therapy risk reduction initiative: impact on urine drug testing rates and results.
Turner JA; Saunders K; Shortreed SM; Rapp SE; Thielke S; LeResche L; Riddell KM; Von Korff M
J Gen Intern Med; 2014 Feb; 29(2):305-11. PubMed ID: 24142119
[TBL] [Abstract][Full Text] [Related]
13. Naltrexone and buprenorphine combination in the treatment of opioid dependence.
Gerra G; Fantoma A; Zaimovic A
J Psychopharmacol; 2006 Nov; 20(6):806-14. PubMed ID: 16401652
[TBL] [Abstract][Full Text] [Related]
14. Buprenorphine adherence and illicit opioid use among patients in treatment for opioid use disorder.
Bhatraju EP; Radick AC; Leroux BG; Kim TW; Samet JH; Tsui JI
Am J Drug Alcohol Abuse; 2023 Jul; 49(4):511-518. PubMed ID: 37369019
[No Abstract] [Full Text] [Related]
15. A Descriptive analysis of urine drug screen results in patients with opioid use disorder managed in a primary care setting.
Sobel HG; Warrington JS; Francis-Fath S; Crocker AM; Berger CA
Addict Sci Clin Pract; 2021 Sep; 16(1):59. PubMed ID: 34593036
[TBL] [Abstract][Full Text] [Related]
16. Collaborative care of opioid-addicted patients in primary care using buprenorphine: five-year experience.
Alford DP; LaBelle CT; Kretsch N; Bergeron A; Winter M; Botticelli M; Samet JH
Arch Intern Med; 2011 Mar; 171(5):425-31. PubMed ID: 21403039
[TBL] [Abstract][Full Text] [Related]
17. Polysubstance Use Among Patients Treated With Buprenorphine From a National Urine Drug Test Database.
Saloner B; Whitley P; LaRue L; Dawson E; Huskey A
JAMA Netw Open; 2021 Sep; 4(9):e2123019. PubMed ID: 34505888
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence.
Montoya ID; Gorelick DA; Preston KL; Schroeder JR; Umbricht A; Cheskin LJ; Lange WR; Contoreggi C; Johnson RE; Fudala PJ
Clin Pharmacol Ther; 2004 Jan; 75(1):34-48. PubMed ID: 14749690
[TBL] [Abstract][Full Text] [Related]
19. Do Urine Drug Tests Reveal Substance Misuse Among Patients Prescribed Opioids for Chronic Pain?
Larochelle MR; Cruz R; Kosakowski S; Gourlay DL; Alford DP; Xuan Z; Krebs EE; Yan S; Lasser KE; Samet JH; Liebschutz JM
J Gen Intern Med; 2022 Aug; 37(10):2365-2372. PubMed ID: 34405344
[TBL] [Abstract][Full Text] [Related]
20. Definitive urine drug testing in office-based opioid treatment: a literature review.
Barthwell AG; Allgaier J; Egli K
Crit Rev Toxicol; 2018 Nov; 48(10):829-852. PubMed ID: 30794024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
